Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

679.95

06-Feb-2025

Open
High
Low
Previous Close

734.00
747.00
662.40
636.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

9249272
65138.66
837.25
399.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,923.83
27.77
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,249.98
0.39%
3.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
13.47

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
21.06

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 22.14
P/E Ratio 28.34
Revenue 1468
EBITDA 346
Net Income 201
ROA 9.4
P/Bk Ratio 3.51
ROE 13.11
FCFF 46.61
FCFF Yield 0.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 470.95 373.03 26.25% 377.29 356.14 5.94% 393.49 358.14 9.87% 414.82 374.27 10.83%
Expenses 355.96 284.75 25.01% 292.52 282.34 3.61% 309.83 281.40 10.10% 307.48 297.47 3.37%
EBITDA 114.99 88.28 30.26% 84.77 73.80 14.86% 83.65 76.74 9.00% 107.34 76.80 39.77%
EBIDTM 24.42% 23.67% 22.47% 20.72% 21.26% 21.43% 25.88% 20.52%
Other Income 11.94 0.20 5,870.00% 2.95 0.00 0 2.11 4.86 -56.58% 5.68 0.00 0
Interest 9.70 4.10 136.59% 5.39 3.82 41.10% 4.25 4.03 5.46% 4.42 5.80 -23.79%
Depreciation 21.04 16.94 24.20% 18.89 16.32 15.75% 18.29 15.44 18.46% 17.32 14.25 21.54%
PBT 96.18 67.44 42.62% 63.43 53.66 18.21% 63.23 62.13 1.77% 91.28 56.75 60.85%
Tax 22.66 19.25 17.71% 15.60 11.85 31.65% 16.08 14.50 10.90% 28.26 16.75 68.72%
PAT 73.52 48.19 52.56% 47.84 41.81 14.42% 47.14 47.63 -1.03% 63.02 40.00 57.55%
PATM 15.61% 12.92% 12.68% 11.74% 11.98% 13.30% 15.19% 10.69%
EPS 8.12 5.32 52.63% 5.28 4.61 14.53% 5.20 5.26 -1.14% 6.96 4.42 57.47%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 537.78 448.69 19.86% 458.03 439.80 4.15% 555.49 458.36 21.19% 505.77 485.06 4.27%
Expenses 409.17 353.01 15.91% 364.35 351.81 3.56% 459.03 373.49 22.90% 388.25 405.07 -4.15%
EBITDA 128.61 95.68 34.42% 93.67 87.99 6.46% 96.46 84.87 13.66% 117.52 79.99 46.92%
EBIDTM 23.91% 21.32% 20.45% 20.01% 17.36% 18.52% 23.24% 16.49%
Other Income 5.03 1.39 261.87% 4.48 0.98 357.14% 2.22 0.48 362.50% 2.03 0.74 174.32%
Interest 9.97 4.48 122.54% 5.51 3.89 41.65% 4.83 4.17 15.83% 4.68 5.94 -21.21%
Depreciation 23.04 18.77 22.75% 20.88 18.14 15.10% 20.17 17.20 17.27% 19.12 15.95 19.87%
PBT 100.63 73.82 36.32% 71.77 66.94 7.22% 73.68 63.98 15.16% 95.75 58.84 62.73%
Tax 26.64 21.06 26.50% 17.14 15.14 13.21% 18.22 16.89 7.87% 30.50 15.97 90.98%
PAT 73.99 52.76 40.24% 54.62 51.80 5.44% 55.45 47.09 17.75% 65.25 42.87 52.20%
PATM 13.76% 11.76% 11.93% 11.78% 9.98% 10.27% 12.90% 8.84%
EPS 8.16 5.82 40.21% 6.03 5.72 5.42% 6.12 5.20 17.69% 7.20 4.73 52.22%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 1,656.55 1,502.13 1,511.25 941.02 Net Sales Growth 13.34% -0.60% 60.60% Cost Of Goods Sold 806.22 751.97 817.93 451.66 Gross Profit 850.33 750.16 693.32 489.36 GP Margin 51.33% 49.94% 45.88% 52.00% Total Expenditure 1,265.79 1,155.97 1,202.91 761.24 Power & Fuel Cost - 82.92 74.22 69.73 % Of Sales - 5.52% 4.91% 7.41% Employee Cost - 120.15 113.92 79.98 % Of Sales - 8.00% 7.54% 8.50% Manufacturing Exp. - 99.70 96.20 132.62 % Of Sales - 6.64% 6.37% 14.09% General & Admin Exp. - 28.39 29.30 6.98 % Of Sales - 1.89% 1.94% 0.74% Selling & Distn. Exp. - 49.19 48.54 20.25 % Of Sales - 3.27% 3.21% 2.15% Miscellaneous Exp. - 23.65 22.80 0.01 % Of Sales - 1.57% 1.51% 0.00% EBITDA 390.75 346.16 308.34 179.78 EBITDA Margin 23.59% 23.04% 20.40% 19.10% Other Income 22.68 11.01 1.28 2.51 Interest 23.76 16.63 20.49 11.34 Depreciation 75.54 66.01 55.77 37.23 PBT 314.12 274.52 233.36 133.73 Tax 82.60 73.87 61.63 27.00 Tax Rate 26.30% 26.91% 26.41% 20.19% PAT 231.52 200.65 171.73 106.73 PAT before Minority Interest 231.52 200.65 171.73 106.73 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 13.98% 13.36% 11.36% 11.34% PAT Growth 30.34% 16.84% 60.90% EPS 25.55 22.15 18.95 11.78

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 2,057.07 1,852.61 1,945.23 1,199.94 Net Sales Growth 12.29% -4.76% 62.11% Cost Of Goods Sold 1,102.25 1,020.71 1,169.76 637.67 Gross Profit 954.82 831.89 775.48 562.27 GP Margin 46.42% 44.90% 39.87% 46.86% Total Expenditure 1,620.80 1,466.56 1,603.18 994.67 Power & Fuel Cost - 84.03 75.10 90.00 % Of Sales - 4.54% 3.86% 7.50% Employee Cost - 128.03 121.32 85.20 % Of Sales - 6.91% 6.24% 7.10% Manufacturing Exp. - 107.30 98.78 145.95 % Of Sales - 5.79% 5.08% 12.16% General & Admin Exp. - 30.08 30.20 8.13 % Of Sales - 1.62% 1.55% 0.68% Selling & Distn. Exp. - 68.88 74.83 27.38 % Of Sales - 3.72% 3.85% 2.28% Miscellaneous Exp. - 27.53 33.20 0.34 % Of Sales - 1.49% 1.71% 0.03% EBITDA 436.26 386.05 342.05 205.27 EBITDA Margin 21.21% 20.84% 17.58% 17.11% Other Income 13.76 4.89 2.32 4.19 Interest 24.99 17.21 21.05 11.96 Depreciation 83.21 73.24 62.54 42.12 PBT 341.83 300.49 260.77 155.38 Tax 92.50 83.59 67.28 33.13 Tax Rate 27.06% 27.82% 25.80% 21.32% PAT 249.31 216.90 193.49 122.25 PAT before Minority Interest 249.31 216.90 193.49 122.25 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 12.12% 11.71% 9.95% 10.19% PAT Growth 28.17% 12.10% 58.27% EPS 27.52 23.94 21.36 13.49

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,621.46 1,438.58 1,284.28 Share Capital 45.31 45.31 0.25 Total Reserves 1,575.92 1,393.27 1,238.71 Non-Current Liabilities 119.87 74.04 60.88 Secured Loans 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 5.28 4.66 0.00 Current Liabilities 555.58 463.75 481.67 Trade Payables 254.79 212.50 131.61 Other Current Liabilities 43.76 36.20 8.98 Short Term Borrowings 250.80 206.71 324.62 Short Term Provisions 6.24 8.33 16.46 Total Liabilities 2,296.91 1,976.37 1,826.83 Net Block 953.33 848.40 701.12 Gross Block 1,472.15 1,303.76 1,100.71 Accumulated Depreciation 518.82 455.37 399.59 Non Current Assets 1,162.85 1,010.15 936.56 Capital Work in Progress 136.92 101.90 187.37 Non Current Investment 43.83 42.67 39.87 Long Term Loans & Adv. 28.77 17.18 8.21 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,134.06 966.22 890.27 Current Investments 17.83 12.81 0.00 Inventories 582.15 537.68 444.38 Sundry Debtors 448.82 371.67 304.22 Cash & Bank 4.43 0.37 56.50 Other Current Assets 80.83 7.18 11.53 Short Term Loans & Adv. 66.86 36.51 73.65 Net Current Assets 578.48 502.47 408.60 Total Assets 2,296.91 1,976.37 1,826.83

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,757.04 1,558.49 1,386.48 Share Capital 45.31 45.31 0.25 Total Reserves 1,711.50 1,513.17 1,340.91 Non-Current Liabilities 130.68 84.91 72.76 Secured Loans 0.04 0.18 0.55 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 6.06 5.36 0.00 Current Liabilities 694.39 600.62 580.67 Trade Payables 378.32 339.50 214.59 Other Current Liabilities 45.84 38.33 11.89 Short Term Borrowings 263.92 213.78 337.73 Short Term Provisions 6.31 9.01 16.46 Total Liabilities 2,582.11 2,244.02 2,039.91 Net Block 1,033.33 925.84 782.09 Gross Block 1,609.29 1,431.25 1,225.00 Accumulated Depreciation 575.96 505.41 442.90 Non Current Assets 1,236.46 1,081.02 1,011.75 Capital Work in Progress 136.92 101.87 187.37 Non Current Investment 36.78 35.52 32.23 Long Term Loans & Adv. 29.44 17.78 10.07 Other Non Current Assets 0.00 0.00 0.00 Current Assets 1,345.64 1,163.01 1,028.15 Current Investments 70.39 50.99 0.00 Inventories 642.86 602.04 475.45 Sundry Debtors 519.34 450.10 376.66 Cash & Bank 24.07 12.19 83.27 Other Current Assets 88.98 7.70 10.74 Short Term Loans & Adv. 71.97 39.98 82.03 Net Current Assets 651.25 562.38 447.48 Total Assets 2,582.10 2,244.03 2,039.90

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 183.69 215.88 -64.84 PBT 274.52 233.36 133.73 Adjustment 80.71 76.87 46.08 Changes in Working Capital -124.55 -37.61 -229.65 Cash after chg. in Working capital 230.68 272.61 -49.84 Interest Paid 0.00 0.00 0.00 Tax Paid -46.99 -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -184.40 -115.55 -133.54 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others 25.19 17.64 Cash from Financing Activity 4.40 -156.53 254.63 Net Cash Inflow / Outflow 3.70 -56.20 56.25 Opening Cash & Equivalents 0.30 56.50 0.25 Closing Cash & Equivalent 4.00 0.30 56.50

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 216.35 250.12 -43.70 PBT 300.49 260.77 155.38 Adjustment 94.65 83.35 52.41 Changes in Working Capital -121.85 -31.63 -230.36 Cash after chg. in Working capital 273.29 312.50 -22.57 Interest Paid 0.00 0.00 0.00 Tax Paid -56.94 -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -214.56 -157.80 -138.74 Net Fixed Assets -203.41 -117.58 Net Investments -6.18 -15.61 Others -4.97 -24.61 Cash from Financing Activity 9.72 -163.46 260.38 Net Cash Inflow / Outflow 11.51 -71.15 77.94 Opening Cash & Equivalents 12.12 83.27 5.33 Closing Cash & Equivalent 23.63 12.12 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 178.89 158.74 49558.52 ROA 9.39% 9.03% 11.68% ROE 13.11% 12.83% 17.23% ROCE 16.55% 15.60% 18.03% Fixed Asset Turnover 1.08 1.26 0.85 Receivable days 99.68 81.62 118.00 Inventory Days 136.05 118.59 172.36 Payable days 113.41 76.78 53.18 Cash Conversion Cycle 122.33 123.44 237.18 Total Debt/Equity 0.15 0.14 0.26 Interest Cover 17.50 12.39 12.79

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 193.85 171.97 53646.60 ROA 8.99% 9.03% 11.98% ROE 13.08% 13.35% 18.23% ROCE 16.75% 16.11% 19.40% Fixed Asset Turnover 1.22 1.46 0.98 Receivable days 95.50 77.57 114.57 Inventory Days 122.63 101.09 144.62 Payable days 128.34 86.45 61.41 Cash Conversion Cycle 89.79 92.21 197.78 Total Debt/Equity 0.15 0.14 0.25 Interest Cover 18.46 13.39 13.99

Top Investors:

life insurance corporation of india

quant mutual fund - quant small cap fund

ntasain discovery master fund

nishant pradip shah

morgan stanley investment funds emerging leaders equity fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs - Quarterly Results
5th Feb 2025, 19:11 PM

Read More
Aarti Pharmalabs enters into agreement with Pro-zeal Green Power
10th Jan 2025, 16:42 PM

Cost of acquisition is Rs 2.97 crore
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback